Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

522
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
522
Structure and Function of Platelets01:18

Structure and Function of Platelets

1.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.1K
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

6.1K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Harnessing Vδ1<sup>+</sup> T cells for next-generation immunotherapy: from mechanistic insights to clinical translation.

Frontiers in immunology·2026
Same author

Mendelian randomization analysis of 1,400 genetically predicted blood metabolites and ovarian cancer risk.

Archives of medical science : AMS·2026
Same author

Shared genetic architecture between ADHD and intelligence varies across ADHD subtypes.

BMC medicine·2026
Same author

A structurally reassembled sunflower stem pith composite sponge for prehospital temporary emergency hemostasis.

Biomaterials science·2026
Same author

Zinc-chelated cuttlefish ink melanin nanoparticle-complexed sprayable chitosan-based hydrogel for promoting infected wound healing.

Biomaterials science·2026
Same author

Learning Evolution Via Optimization Knowledge Adaptation.

IEEE transactions on pattern analysis and machine intelligence·2026

Related Experiment Video

Updated: Jul 1, 2025

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

21.7K

Engineering unactivated platelets for targeted drug delivery.

Meng Wu1, Yan Shi1, Jiaxuan Zhao1

  • 1College of Marine Life Sciences, Ocean University of China, Qingdao, Shandong Province, 266003, China. kongming@ouc.edu.cn.

Biomaterials Science
|March 14, 2024
PubMed
Summary

Engineered platelets offer a novel approach for drug delivery, leveraging their natural functions in hemostasis and immunity. This review details methods for creating these platelet drug carriers for treating various diseases.

More Related Videos

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers
05:43

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers

Published on: November 8, 2024

316
Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

546

Related Experiment Videos

Last Updated: Jul 1, 2025

Ferric Chloride-induced Murine Thrombosis Models
10:37

Ferric Chloride-induced Murine Thrombosis Models

Published on: September 5, 2016

21.7K
An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers
05:43

An In Vitro Assay to Study Platelet Migration Using RGD-Functionalized Avidin-Biotin Tethers

Published on: November 8, 2024

316
Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
05:49

Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets

Published on: November 29, 2024

546

Area of Science:

  • Biomedical Engineering
  • Nanotechnology
  • Hematology

Background:

  • Platelets are essential blood components involved in hemostasis, vascular integrity, inflammation, and immune responses.
  • Their unique biological characteristics make them suitable candidates for drug delivery applications.
  • Recent advancements facilitate the creation of engineered platelets using diverse techniques.

Purpose of the Study:

  • To review recent progress in utilizing unactivated platelets as drug delivery vehicles.
  • To summarize construction strategies for engineered platelets.
  • To discuss the therapeutic potential and challenges of engineered platelets.

Main Methods:

  • Internal loading of therapeutic agents into platelets.
  • Surface modification of platelets for targeted delivery.
  • Genetic engineering techniques to imbue platelets with specific functions.

Main Results:

  • Engineered platelets can be constructed through various methods, including internal loading, surface modification, and genetic engineering.
  • These engineered platelets show promise as platforms for immunotherapy and chemokine therapy.
  • Potential applications span cardiovascular diseases, cancers, and infectious diseases.

Conclusions:

  • Engineered platelets represent a promising drug delivery system with broad therapeutic potential.
  • Further research is needed to address challenges in maintaining natural platelet activity in engineered forms.
  • The development of engineered platelets could revolutionize treatment strategies for numerous diseases.